News
Medical Xpress: Rapamycin prevents age-related brain vascular deterioration
Featured in Medical Xpress A just-released study by UT Health San Antonio and collaborating institutions shows age-related decreases in blood flow to the brain and memory loss can be modified with the drug rapamycin. This finding, if furthered, holds implications for aging in general and perhaps offers an avenue to prevent Alzheimer’s dementia in some […]
Read moreBiggs Institute seeks 10 volunteers for study of Alzheimer’s drug
The Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio is recruiting volunteers for a clinical study of an investigational drug for Alzheimer’s disease. The principal investigator for this study is Sudha Seshadri, M.D., professor of neurology at UT Health San Antonio and director of the Glenn Biggs Institute. The Biggs […]
Read more5th Edition Neurepiomics Course
The Biggs Institute at UT Health San Antonio hosted the 5th Edition of the Neurepiomics Course October 18-22, 2019. The course offers interactive extensive training with practical demonstrations in advanced research methods of neurepidemiology with experts from around the world and has previously been hosted at sights like Boston, Massachusetts and Bordeaux, France.
Read moreGene variants influence size of brain stem, other structures
Global research project suggests novel drug targets for brain diseases Researchers have found a link between 48 common genetic variations and the size of the brainstem and other subcortical structures deep within the brain. These structures control a wide array of functions ranging from learning and fear response to heart rate and voluntary movement. Damage […]
Read moreNeurology Today: Elevated Plasma Tau Predicts Stroke Risk Over and Above Other Factors
By Richard Robinson ARTICLE IN BRIEF:In blood samples from participants in the longitudinal Framingham Heart Study, researchers applied a highly sensitive test for total tau and found that those with higher levels had an increased risk for stroke. Elevation of tau in the bloodstream is an independent risk factor for stroke, according to a study […]
Read moreLargest study of CTE finds it in 6% of subjects
Nearly 6% of athletes and non-athletes were found to have the neurodegenerative disorder chronic traumatic encephalopathy (CTE) in the largest, and broadest, study conducted of the disease to date. The findings were published June 14 in the international journal Brain Pathology. “Generally our findings point to CTE being more common in athletes and more common in football […]
Read moreDr. Gonzales named RL5 scholar
Mitzi Gonzales, Ph.D., assistant professor of neurology and member of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Disorders, has been named to the RL5 Scholars program. The NIH funded position supported by the Pepper Center “supports early career investigators appointed by an institution for activities related to the development of a successful clinical and […]
Read moreKSAT 12: Local scientists help discover new genes to identify risk for Alzheimer’s
Trend shows later onset of dementia, fewer years of the disease
The diagnosis is one that a family never wants to hear: Your father has Alzheimer’s disease. Your mother has stroke-related dementia. Sudha Seshadri, M.D. A recently released study, included in a special supplement to the Journal of Gerontology, indicates that dementia’s impact might be compressing a bit. That is, people might be developing dementia later and […]
Read moreResearcher selected to participate in program to study Alzheimer’s-vascular interplay
Bernard Fongang, Ph.D. Bernard Fongang, Ph.D., of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases and assistant professor in the Department of Biochemistry and Structural Biology and the Department of Epidemiology and Biostatistics, has been selected to participate in the PRIDE CVD-CGE Program, a research enrichment activity offered by Washington University at St. Louis. The primary objective of the […]
Read more